• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

下肢缺血局部动脉内溶栓治疗出血的危险因素。

Risk factors for haemorrhage during local intra-arterial thrombolysis for lower limb ischaemia.

机构信息

Vascular Center, Malmö University Hospital, 20502 Malmö, Sweden.

出版信息

J Thromb Thrombolysis. 2011 Feb;31(2):226-32. doi: 10.1007/s11239-010-0520-2.

DOI:10.1007/s11239-010-0520-2
PMID:20848161
Abstract

Assessment of clinical risk factors for haemorrhagic complications in patients undergoing intra-arterial thrombolysis for lower limb ischaemia. Retrospective reviews of consecutive patients subjected to intra-arterial thrombolysis due to lower limb ischemia at the Vascular Center, Malmö University Hospital, during a 5-year period from 2001 to 2005. Two hundred and twenty intra-arterial thrombolytic procedures were carried out in 195 patients (46% women), median age 73 years. Haemorrhagic complications were recorded in 72 procedures (33%), of which 13 were discontinued. Haemorrhage at the introducer and distant sites occurred in 53 and 32 procedures, respectively. Thrombolysis for occluded synthetic grafts was associated with higher risk of haemorrhage (P = 0.043). The platelet count was lower (P = 0.017) and the dose of alteplas higher (P = 0.041) in bleeders than in non-bleeders. Age was not associated with haemorrhage (P = 0.30). Two patients died during thrombolysis, one of them due to intracerebral haemorrhage. The grade of thrombolysis was an independent predictor of both in-hospital amputation (P < 0.001; OR 3.5 [95% CI 2.1-5.8]) and mortality (P = 0.021; OR 3.0 [95% CI 1.2-7.9]). The in-hospital amputation-free survival rate was 85% (188/220). Haemorrhage associated with thrombolysis is common, but does seldom require discontinuation of treatment. Insertion of introducers for local thrombolysis through synthetic grafts, lower platelet count and higher alteplas dose were found to be risk factors for haemorrhage. An algorithm for clinical management of haemorrhage has been proposed.

摘要

评估下肢缺血患者行动脉内溶栓治疗的出血并发症的临床危险因素。对 2001 年至 2005 年期间在马尔默大学医院血管中心因下肢缺血接受动脉内溶栓治疗的连续患者进行回顾性分析。195 例患者(46%为女性)共行 220 次动脉内溶栓治疗,中位年龄 73 岁。72 次(33%)出现出血并发症,其中 13 次停止治疗。分别有 53 次和 32 次出现导丝入口和远处部位出血。闭塞的合成移植物溶栓与更高的出血风险相关(P = 0.043)。出血患者的血小板计数较低(P = 0.017),alteplas 剂量较高(P = 0.041)。年龄与出血无关(P = 0.30)。2 例患者在溶栓过程中死亡,其中 1 例死于脑出血。溶栓后的分级是住院截肢(P < 0.001;OR 3.5 [95% CI 2.1-5.8])和死亡率(P = 0.021;OR 3.0 [95% CI 1.2-7.9])的独立预测因子。住院无截肢生存率为 85%(188/220)。溶栓相关出血较为常见,但很少需要停止治疗。经合成移植物插入局部溶栓导丝、血小板计数较低和 alteplas 剂量较高被认为是出血的危险因素。已经提出了一种用于出血临床管理的算法。

相似文献

1
Risk factors for haemorrhage during local intra-arterial thrombolysis for lower limb ischaemia.下肢缺血局部动脉内溶栓治疗出血的危险因素。
J Thromb Thrombolysis. 2011 Feb;31(2):226-32. doi: 10.1007/s11239-010-0520-2.
2
Update on intra-arterial thrombolysis in patients with lower limb ischemia.下肢缺血患者动脉内溶栓治疗的最新进展。
J Cardiovasc Surg (Torino). 2015 Apr;56(2):317-24. Epub 2014 Dec 16.
3
Long-term prognostic factors after thrombolysis for lower limb ischemia.下肢缺血溶栓后的长期预后因素。
J Vasc Surg. 2008 Jun;47(6):1243-50. doi: 10.1016/j.jvs.2008.01.053.
4
Independent factors predicting early lower limb intra-arterial thrombolysis failure.预测早期下肢动脉内溶栓失败的独立因素。
Ann Vasc Surg. 2014 Jan;28(1):164-9. doi: 10.1016/j.avsg.2012.11.016. Epub 2013 Sep 5.
5
Survival of Patients and Treatment-Related Outcome After Intra-Arterial Thrombolysis for Acute Lower Limb Ischemia.急性下肢缺血动脉内溶栓治疗后患者的生存情况及治疗相关结局
Ann Vasc Surg. 2019 Feb;55:251-259. doi: 10.1016/j.avsg.2018.07.041. Epub 2018 Sep 29.
6
Endovascular therapy for acute limb ischemia.急性肢体缺血的血管内治疗。
J Vasc Surg. 2011 Feb;53(2):340-6. doi: 10.1016/j.jvs.2010.08.064. Epub 2010 Nov 3.
7
Outcome after thrombolysis for occluded endoprosthesis, bypasses and native arteries in patients with lower limb ischemia.
Thromb Res. 2014 Jul;134(1):23-8. doi: 10.1016/j.thromres.2014.02.030. Epub 2014 Mar 5.
8
Long-term Outcome after Thrombolysis for Acute Lower Limb Ischaemia.急性下肢缺血溶栓治疗后的长期预后
Eur J Vasc Endovasc Surg. 2017 Jun;53(6):853-861. doi: 10.1016/j.ejvs.2017.02.003. Epub 2017 Mar 11.
9
Low-dose thrombolysis for thromboembolic lower extremity arterial occlusions is effective without major hemorrhagic complications.低剂量溶栓治疗血栓栓塞性下肢动脉闭塞症有效,且无重大出血并发症。
Eur J Vasc Endovasc Surg. 2014 Nov;48(5):551-8. doi: 10.1016/j.ejvs.2014.06.042. Epub 2014 Aug 6.
10
Prognostic risk factors for recurrent acute lower limb ischemia in patients treated with intra-arterial thrombolysis.经动脉内溶栓治疗的患者中复发性急性下肢缺血的预后危险因素。
J Vasc Surg. 2020 Apr;71(4):1268-1275. doi: 10.1016/j.jvs.2019.07.061. Epub 2019 Sep 5.

引用本文的文献

1
Catheter-Directed Thrombolysis in the Management of Thrombotic Peripheral Artery Occlusions-Acute and Mid-Term Clinical Outcomes.导管定向溶栓治疗血栓性外周动脉闭塞症——急性和中期临床结果
J Clin Med. 2024 Sep 26;13(19):5732. doi: 10.3390/jcm13195732.
2
Predictors of bleeding complications during catHeter-dirEcted thrombolysis for peripheral arterial occlusions (POCHET).经皮导管溶栓治疗外周动脉闭塞(POCHET)过程中出血并发症的预测因素。
PLoS One. 2024 May 9;19(5):e0302830. doi: 10.1371/journal.pone.0302830. eCollection 2024.
3
Dose-Response Relationship and Threshold Drug Dosage Identification for a Novel Hybrid Mechanical-Thrombolytic System with an Ultra-Low Dose Patch.

本文引用的文献

1
Can catheter-directed thrombolysis be applied to acute lower extremity artery embolism after recent cerebral embolism from atrial fibrillation?在近期发生心房颤动所致脑栓塞后,导管定向溶栓能否应用于急性下肢动脉栓塞?
Clin Radiol. 2008 Oct;63(10):1136-41. doi: 10.1016/j.crad.2008.04.014. Epub 2008 Jul 7.
2
Antithrombotic therapy for peripheral artery occlusive disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).外周动脉闭塞性疾病的抗栓治疗:美国胸科医师学会循证临床实践指南(第8版)
Chest. 2008 Jun;133(6 Suppl):815S-843S. doi: 10.1378/chest.08-0686.
3
Hemorrhagic complications of anticoagulant and thrombolytic treatment: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).
一种带有超低剂量贴片的新型混合机械溶栓系统的剂量-反应关系及阈值药物剂量鉴定
Cell Mol Bioeng. 2021 Jun 10;14(6):627-637. doi: 10.1007/s12195-021-00683-y. eCollection 2021 Dec.
4
Endovascular revascularization strategies using catheter-based thrombectomy versus conventional catheter-directed thrombolysis for acute limb ischemia.采用基于导管的血栓切除术与传统导管定向溶栓术治疗急性肢体缺血的血管内血运重建策略。
Thromb J. 2021 Dec 4;19(1):96. doi: 10.1186/s12959-021-00349-9.
5
Acute Limb Ischemia: An Update on Diagnosis and Management.急性肢体缺血:诊断与治疗的最新进展
J Clin Med. 2019 Aug 14;8(8):1215. doi: 10.3390/jcm8081215.
6
Outcome and complications after intra-arterial thrombolysis for lower limb ischaemia with or without continuous heparin infusion.经动脉内溶栓治疗下肢缺血的疗效和并发症,有无持续肝素输注。
Br J Surg. 2014 Aug;101(9):1105-12. doi: 10.1002/bjs.9579. Epub 2014 Jun 25.
7
Percutaneous mechanical thrombectomy of superior mesenteric artery embolism.经皮机械取栓术治疗肠系膜上动脉栓塞。
Radiol Oncol. 2013 Jul 30;47(3):239-43. doi: 10.2478/raon-2013-0029. eCollection 2013.
8
Mechanically assisted intra-arterial thrombolysis in acute cerebral infarction.急性脑梗死的机械辅助动脉内溶栓治疗
Exp Ther Med. 2013 May;5(5):1444-1450. doi: 10.3892/etm.2013.990. Epub 2013 Mar 6.
抗凝和溶栓治疗的出血并发症:美国胸科医师学会循证临床实践指南(第8版)
Chest. 2008 Jun;133(6 Suppl):257S-298S. doi: 10.1378/chest.08-0674.
4
Long-term prognostic factors after thrombolysis for lower limb ischemia.下肢缺血溶栓后的长期预后因素。
J Vasc Surg. 2008 Jun;47(6):1243-50. doi: 10.1016/j.jvs.2008.01.053.
5
Successful emergency reversal of phenprocoumon anticoagulation with prothrombin complex concentrate: a prospective clinical study.凝血酶原复合物浓缩剂成功紧急逆转苯丙香豆素抗凝作用:一项前瞻性临床研究。
Blood Coagul Fibrinolysis. 2007 Sep;18(6):565-70. doi: 10.1097/MBC.0b013e3282010d7a.
6
Role of prothrombin complex concentrates in reversing warfarin anticoagulation: a review of the literature.凝血酶原复合物浓缩剂在逆转华法林抗凝作用中的作用:文献综述
Am J Hematol. 2008 Feb;83(2):137-43. doi: 10.1002/ajh.21046.
7
Coagulation factor concentrates: past, present, and future.凝血因子浓缩物:过去、现在与未来。
Lancet. 2007 Aug 4;370(9585):439-48. doi: 10.1016/S0140-6736(07)61199-4.
8
Guidelines on the management of massive blood loss.大量失血管理指南。
Br J Haematol. 2006 Dec;135(5):634-41. doi: 10.1111/j.1365-2141.2006.06355.x.
9
National Audit of Thrombolysis for Acute Leg Ischemia (NATALI): clinical factors associated with early outcome.急性下肢缺血溶栓治疗全国审计(NATALI):与早期预后相关的临床因素
J Vasc Surg. 2004 May;39(5):1018-25. doi: 10.1016/j.jvs.2004.01.019.
10
Infusion techniques for peripheral arterial thrombolysis.外周动脉溶栓的输注技术。
Cochrane Database Syst Rev. 2004(1):CD000985. doi: 10.1002/14651858.CD000985.pub2.